Enzyme deficiency in galactosemia –
**Question:** Enzyme deficiency in galactosemia -
A. Galactokinase deficiency
B. GALK deficiency
C. GALE deficiency
D. GALT deficiency
**Correct Answer:** D. GALT deficiency
**Core Concept:** Galactosemia is a group of genetic disorders caused by deficiencies in enzymes involved in galactose catabolism. Galactose is a sugar found in lactose, which is present in milk and dairy products. Galactose is converted into glucose through a series of enzymes and reactions.
**Why the Correct Answer is Right:** GALT (galactose-1-phosphate uridyltransferase) deficiency is the correct answer because it is the most common form of galactosemia. GALT deficiency affects the final step of galactose catabolism, where galactose-1-phosphate is converted into UDP-galactose. This deficiency leads to the accumulation of galactose-1-phosphate, which is toxic to various organs, particularly the liver and brain.
**Why Each Wrong Option is Incorrect:**
A. Galactokinase deficiency (GALK) is responsible for the initial step in galactose catabolism, converting galactose into galactose-1-phosphate. A deficiency in GALK would result in impaired galactose utilization, not accumulation.
B. GALE deficiency (galactose-1-phosphate uridyl-lyase) is involved in the breakdown of UDP-galactose into galactose-1-phosphate. A deficiency in GALE would lead to a decrease in UDP-galactose production, not galactose accumulation.
C. GALT deficiency is mentioned above as the correct answer, so it's not necessary to repeat the explanation here.
**Clinical Pearl:** Galactosemia can lead to severe neurological impairment and developmental delays if not diagnosed and treated early. Early diagnosis and dietary restrictions can prevent or significantly reduce these complications.
**Why Early Diagnosis Matters:** Timely diagnosis of galactosemia is crucial to prevent long-term complications. In severe cases, infants with untreated galactosemia can develop neurological damage, liver failure, cataracts, and growth retardation. Early diagnosis involves monitoring for elevated galactose and galactose-1-phosphate levels in urine and blood. Once diagnosed, dietary restrictions can prevent the accumulation of galactose and galactose-1-phosphate in patients, reducing the risk of long-term complications.